R Erik Edens
Overview
Explore the profile of R Erik Edens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li S, Watson D, Jorgenson A, Adelekan Z, Tang W, Garland K, et al.
Arterioscler Thromb Vasc Biol
. 2023 Sep;
43(11):2231-2239.
PMID: 37767707
Background: Thrombosis is a major complication after cardiac surgery in children with congenital heart disease. The mechanisms underlying thrombosis development remain poorly understood. We aimed to identify novel circulating metabolites...
2.
Auerbach S, Cantor R, Bradford T, Bock M, Skipper E, Koehl D, et al.
ASAIO J
. 2021 Jul;
68(2):287-296.
PMID: 34264872
To describe the impact of infectious adverse events (IAEs) during ventricular assist device (VAD) support on graft loss, infection, and rejection after pediatric heart transplant (HT). Pedimacs data were linked...
3.
Burstein D, Griffis H, Zhang X, Cantor R, Dai D, Shamszad P, et al.
J Heart Lung Transplant
. 2021 Mar;
40(6):478-487.
PMID: 33744087
Background: Paracorporeal continuous-flow ventricular assist devices (PCF VAD) are increasingly used in pediatrics, yet PCF VAD resource utilization has not been reported to date. Methods: Pediatric Interagency Registry for Mechanically...
4.
Wagner S, Turek J, Maldonado J, Staron M, Edens R
Ann Thorac Surg
. 2018 Aug;
107(1):165-171.
PMID: 30071234
Background: Historically, steroids and endomyocardial biopsies have, respectively, been part of standard immunosuppression for preventing cardiac transplant rejection and monitoring for rejection. However, these treatments come with numerous adverse effects....
5.
Rossano J, Cantor R, Dai D, Shamszad P, Huang Y, Hall M, et al.
J Am Heart Assoc
. 2018 Jun;
7(11).
PMID: 29858364
Background: Few data exist on resource utilization with pediatric ventricular assist devices (VADs). We tested the hypothesis that device type and adverse events are associated with increased resource utilization in...
6.
Kashyap A, Turek J, Wagner S, Felderman L, Jaggers E, Gruber P, et al.
Artif Organs
. 2017 Nov;
42(4):444-451.
PMID: 29105103
The development of a pediatric cardiac support program is a complex, multidisciplinary project. This study describes the University of Iowa Congenital Heart Program's experience from its inception to the present....
7.
Simpson K, Pruitt E, Kirklin J, Naftel D, Singh R, Edens R, et al.
Ann Thorac Surg
. 2016 Nov;
103(4):1315-1320.
PMID: 27863728
Background: Historically, patients with a prior Fontan procedure for complex congenital heart disease (CHD) have been considered at higher risk for death after heart transplant (HT) compared with other HT...
8.
Edens R, Gruber P
J Thorac Cardiovasc Surg
. 2016 May;
151(6):1527-8.
PMID: 27207122
No abstract available.
9.
Kenleigh D, Edens R, Bates M, Turek J
World J Pediatr Congenit Heart Surg
. 2015 Apr;
6(2):339-41.
PMID: 25870363
Background: The HeartWare Ventricular Assist System is indicated to provide mechanical circulatory support of patients with intractable heart failure as a bridge to cardiac transplantation. We describe the use of...
10.
Pietra B, Kantor P, Bartlett H, Chin C, Canter C, Larsen R, et al.
Circulation
. 2012 Jul;
126(9):1079-86.
PMID: 22800850
Background: The importance of clinical presentation and pretransplantation course on outcome in children with dilated cardiomyopathy listed for heart transplantation is not well defined. Methods And Results: The impact of...